The document presents a comprehensive overview of the strategies and considerations involved in resuming on-campus research activities as COVID-19 restrictions are lifted. A panel of experts from leading research institutions discussed a range of topics including preparatory planning, building readiness, support services, and the operational complexities that universities face in ensuring a safe ramp-up. Key issues addressed include the need for robust planning teams, protocols for PPE access, maintaining low-density work environments, and remote work continuance where feasible. The meticulous walkthrough of the full research life cycle highlights the necessity to adapt every step—from laboratory procedures to administrative and support functions—to account for COVID-19 related risks and requirements.
Further, the document delineates special considerations for various types of research, such as animal and human subjects research, emphasizing factors like supply chain management, regulatory adherence, and participant safety. The importance of both internal readiness (including staff health monitoring, contingency planning for potential retrenchment, and robust screening and testing procedures) and external coordination (with industry sponsors and regulatory bodies) is underscored. Challenges such as supporting high-risk populations, ensuring equity in resource allocation, and enabling consistent communication are acknowledged. The overall message reinforces the need for flexibility, stakeholder engagement, and adaptable protocols, given the evolving public health landscape and diverse research environments.
